Guidelines on prevention, diagnosis and treatment of infective endocarditis - Executive summary

被引：454

作者：

Horstkotte, D ^{[1
]}

Follath, F ^{[1
]}

Gutschik, E ^{[1
]}

Lengyel, M ^{[1
]}

Oto, A ^{[1
]}

Pavie, A ^{[1
]}

Soler-soler, J ^{[1
]}

Thiene, G ^{[1
]}

von Graevenitz, A ^{[1
]}

机构：

[1] Ruhr Univ Bochum, Heart Ctr N Rhine Westphalia, Dept Cardiol, D-32545 Bad Oeynhausen, Germany

来源：

EUROPEAN HEART JOURNAL | 2004年 / 25卷 / 03期

关键词：

D O I：

10.1016/j.ehj.2003.11.008

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：267 / 276

页数：10

共 105 条

[1]

ARBULU A, 1981, J THORAC CARDIOV SUR, V82, P684

[2] CURRENT CONCEPTS IN PREVENTION OF PROSTHETIC VALVE ENDOCARDITIS [J].

BAYER, AS ;

NELSON, RJ ;

SLAMA, TG .

CHEST, 1990, 97 (05) :1203-1207

[3] EVALUATION OF NEW CLINICAL-CRITERIA FOR THE DIAGNOSIS OF INFECTIVE ENDOCARDITIS [J].

BAYER, AS ;

WARD, JI ;

GINZTON, LE ;

SHAPIRO, SM .

AMERICAN JOURNAL OF MEDICINE, 1994, 96 (03) :211-219

[4] DISSEMINATED CANDIDIASIS IN ADDICTS WHO USE BROWN HEROIN - REPORT OF 83 CASES AND REVIEW [J].

BISBE, J ;

MIRO, JM ;

LATORRE, X ;

MORENO, A ;

MALLOLAS, J ;

GATELL, JM ;

DELABELLACASA, JP ;

SORIANO, E .

CLINICAL INFECTIOUS DISEASES, 1992, 15 (06) :910-923

[5] PERSISTENT FEVER IN ASSOCIATION WITH INFECTIVE ENDOCARDITIS [J].

BLUMBERG, EA ;

ROBBINS, N ;

ADIMORA, A ;

LOWY, FD .

CLINICAL INFECTIOUS DISEASES, 1992, 15 (06) :983-990

[6] Guidelines for the management of patients with valvular heart disease - Executive summary - A report of the American College of Cardiology American Heart Association task force on practice guidelines (committee on management of patients with valvular heart disease) [J].

Bonow, RO ;

Carabello, B ;

de Leon, AC ;

Edmunds, LH ;

Fedderly, BJ ;

Freed, MD ;

Gaasch, WH ;

McKay, CR ;

Nishimura, RA ;

O'Gara, PT ;

O'Rourke, RA ;

Rahimtoola, SH ;

Ritchie, JL ;

Cheitlin, MD ;

Eagle, KA ;

Gardner, TJ ;

Garson, A ;

Gibbons, RJ ;

Russell, RO ;

Ryan, TJ ;

Smith, SC .

CIRCULATION, 1998, 98 (18) :1949-1984

[7] ACC/AHA guidelines for the management of patients with valvular heart disease - A report of the American College of Cardiology American Heart Association Task Force on practice guidelines (Committee on Management of Patients with Valvular Heart Disease) [J].

Bonow, RO ;

Carabello, B ;

De Leon, AC ;

Edmunds, LH ;

Fedderly, BJ ;

Freed, MD ;

Gaasch, WH ;

Mckay, CR ;

Nishimura, RA ;

O'Gara, PT ;

O'Rourke, RA ;

Rahimtoola, SH .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (05) :1486-1582

[8] In vivo antibacterial effects of simulated human serum profiles of once-daily versus thrice-daily dosing of amikacin in a Serratia marcescens endocarditis experimental model [J].

Bugnon, D ;

Potel, G ;

Xiong, YQ ;

Caillon, J ;

Kergueris, MF ;

LeConte, P ;

Baron, D ;

Drugeon, H .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (05) :1164-1169

[9] Immunoblotting in the diagnosis of culture negative endocarditis caused by streptococci and enterococci [J].

Burnie, JP ;

Clark, I .

JOURNAL OF CLINICAL PATHOLOGY, 1995, 48 (12) :1130-1136

[10]

CARBON C, 1998, CLIN MICROBIOL INFEC, V4, pS27

← 1 2 3 4 5 6 7 8 9 10 →